Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …

Novartis’ long-standing chief executive and chairman, Daniel Vasella is to step down from his dual position to focus upon his …
Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …
Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …

Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …


